Medizinische Klinik IV Diabetologie

Bad Homburg vor der Höhe, Germany

Medizinische Klinik IV Diabetologie

Bad Homburg vor der Höhe, Germany
SEARCH FILTERS
Time filter
Source Type

Obesity is a chronic disease, which is associated with an increased risk for comorbidities and mortality. An interdisciplinary strategy for successful treatment of obesity includes dietary counseling, an increase in physical activity and behavioral therapy. Before any attempts at weight reduction are initiated, the medication of obese subjects should be checked and optimized with respect to possible adipogenic effects. If life style interventions do not result in a weight loss of at least 5% of the original body weight, adjuvant pharmacotherapy should be considered. In Germany, there are currently only two substances available for the treatment of obesity, orlistat and liraglutide, of which, liraglutide at a daily dose of 3.0 mg by subcutaneous injection is significantly more potent than orlistat with respect to the desired weight loss. © 2017, Springer Medizin Verlag Berlin.

Loading Medizinische Klinik IV Diabetologie collaborators
Loading Medizinische Klinik IV Diabetologie collaborators